Intas Pharmaceuticals Ltd - Company Profile
Powered by 
All the data and insights you need on Intas Pharmaceuticals Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Intas Pharmaceuticals Ltd Strategy Report
- Understand Intas Pharmaceuticals Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Intas Pharmaceuticals Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 26 Jul 2022 | Prestige Biopharma and Intas Pharma Enter into Agreement | Partnership | - |
Intas Pharmaceuticals Ltd
Prestige BioPharma Ltd
|
| 09 May 2022 | Accord Healthcare Enters into Licensing Agreement with Myovant Sciences | Licensing Agreement |
Accord Healthcare Ltd
|
Myovant Sciences Ltd |
| 27 Apr 2022 | Abu Dhabi Investment Authority to Acquire 3% Stake in Intas Pharma from Temasek Holdings | Private Equity |
Abu Dhabi Investment Authority
|
Intas Pharmaceuticals Ltd |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer